Sort
10,766 grants matching “checkpoint inhibitor”
Targeting interplay between KLF4 and PRMT5 in carcinogenesis
$259,934Yong Wan · Northwestern University At Chicago · R01 · FY2017 · CA
Project 3: Maximizing Anti-tumor Activity through Simultaneous Activation of the Innate and Adaptive Immune System in Kidney Cancer
$259,666Raquibul Hannan · Ut Southwestern Medical Center · P50 · FY2025 · CA
Core D: Translational Imaging Core
$259,666Ivan Pedrosa · Ut Southwestern Medical Center · P50 · FY2025 · CA
Target validation of CD206 activators
$259,560Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy
$259,550Shana O Kelley · Northwestern University · R01 · FY2023 · CA
Investigating nanotube-mediated mitochondria transfer and inhibitor effects in cancer-immune cell interactions across 2D and 3D models
$259,550Shiladitya Sengupta · Brigham And Women'S Hospital · R01 · FY2024 · CA
Role of Neutrophil Extracellular Traps in Pancreatic Cancer
$259,037Brian A Boone · West Virginia University · P20 · FY2024 · GM
Signaling Mechanism of the DNA Replication Checkpoint
$259,000Yongjie Xu · Wright State University · R01 · FY2020 · GM
Signaling Mechanism of the DNA Replication Checkpoint
$259,000Yongjie Xu · Wright State University · R01 · FY2015 · GM
Signaling Mechanism of the DNA Replication Checkpoint
$259,000Yongjie Xu · Wright State University · R01 · FY2017 · GM
Signaling Mechanism of the DNA Replication Checkpoint
$259,000Yongjie Xu · Wright State University · R01 · FY2018 · GM
Signaling Mechanism of the DNA Replication Checkpoint
$259,000Yongjie Xu · Wright State University · R01 · FY2016 · GM
Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis
$258,850David R Spriggs · Sloan-Kettering Inst Can Research · U01 · FY2010 · CA
Early Detection and Immunomodulation of PD-1 Inhibitor Induced Cardiotoxicity
$258,790Saraswati Pokharel · Roswell Park Cancer Institute Corp · R21 · FY2020 · HL
IDENTIFYING BIOMARKERS AND DISSECTING COMBINATORIAL SYNERGIES TO IMPROVE IMMUNE CHECKPOINT INHIBITOR RESPONSE IN BLADDER CANCER
$258,540The Cleveland Clinic Foundation · · FY2020 · Defense Health Agency
Mechanisms of ATR Targeting and Regulation
$258,526University Of Wisconsin Madison · R01 · FY2004 · GM
Mechanisms of ATR Targeting and Regulation
$258,425University Of Wisconsin Madison · R01 · FY2005 · GM
Research Project Pancreatic Cancer
$258,389David G Denardo · Washington University · U54 · FY2024 · CA
PDGF Regulation of Cell Growth and Death
$258,191Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2006 · CA
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer
$258,169Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2019 · CA
Transcriptional silencing by the BCL6 oncoprotein
$258,054Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · CA
Res Proj 2: Molecular Imaging Strategies to Study Cdc25A Regulation in vivo
$258,040Helen M Piwnica-Worms · Washington University · P50 · FY2011 · CA
INDUCTION OF P21 AND P27 IN LIVER AFTER CCL4 INJURY
$258,025University Of Illinois At Chicago · R01 · FY2004 · DK
INDUCTION OF P21 AND P27 IN LIVER AFTER CCL4 INJURY
$258,025University Of Illinois At Chicago · R01 · FY2002 · DK
INDUCTION OF P21 AND P27 IN LIVER AFTER CCL4 INJURY
$258,025University Of Illinois At Chicago · R01 · FY2005 · DK